cbdMD, Inc. has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife and Alvita Tea. The transaction is being pursued through an assignment for the benefit of creditors (ABC), a process for orderly creditor resolution, and requires court approval and customary closing conditions. Based on unaudited financial information, the combined trailing-12-month revenue for the businesses ending June 2026 was approximately $30 million, about 40% above cbdMD's standalone revenue for the same period. The company said the deal would reduce its concentration in hemp-derived products and expand its multi-brand consumer wellness platform, although the combined figure is illustrative and not a forecast of future results.